In summary, we report an accurate and sensitive method to detect mutations and copy number alterations, including the 1p/19q codeletion and the EGFR amplification, using a rapid and cost-effective approach that enables the correct classification of gliomas and facilitates the diagnosis of difficult cases. This evidence concerns the gene EGFR and glioma.